An increased risk of adverse pregnancy and neonatal outcomes has been reported for pregnancies...

Three abstracts presented at the 2022 EULAR Congress shed new light on risk of a wide...

Attendees at UCD’s Charles Institute Seminar Series heard a presentation by Prof Xiaoli Wu on treatment...

The British Society for Rheumatology (BSR) has launched a new guideline for the treatment of psoriatic...

Results presented at the 2022 EULAR Congress show that early achievement of minimal...

Lupus nephritis (LN) is a frequent complication of systemic lupus erythematosus (SLE), and one...

The use of a novel agent, sacituzumab govitecan, an antibody-drug conjugate, resulted...

Ibrutinib combined with bendamustine-rituximab improved PFS by 50 per cent for older patients with newly-diagnosed mantle...

The use of panitumumab plus mFOLFOX6 significantly improved OS in patients with RAS wild-type...

The use of autologous stem cell transplant (ASCT) early in the course of treatment showed a...

The addition of nimotuzumab to gemcitabine increases OS in patients with KRAS wild-type advanced...

New research has provided important insight into what drives metastases in prostate cancer...